|
USP32 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.31539999999897E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.711900E-02 |
| Normal-vs-Stage2 |
1.897680E-02 |
| Normal-vs-Stage3 |
5.8774999978084E-08 |
| Normal-vs-Stage4 |
2.568800E-04 |
| Stage1-vs-Stage2 |
3.627600E-01 |
| Stage1-vs-Stage3 |
1.572400E-04 |
| Stage1-vs-Stage4 |
1.801770E-02 |
| Stage2-vs-Stage3 |
8.580000E-02 |
| Stage2-vs-Stage4 |
3.303600E-01 |
| Stage3-vs-Stage4 |
6.038000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.92480000000317E-05 |
| Normal-vs-AfricanAmerican |
2.744200E-03 |
| Normal-vs-Asian |
6.887800E-01 |
| Caucasian-vs-AfricanAmerican |
3.925600E-01 |
| Caucasian-vs-Asian |
1.378380E-01 |
| AfricanAmerican-vs-Asian |
1.031960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31179999995901E-06 |
| Normal-vs-Female |
3.870400E-02 |
| Male-vs-Female |
1.826100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.600700E-03 |
| Normal-vs-Age(41-60Yrs) |
3.743400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.61599999999718E-05 |
| Normal-vs-Age(81-100Yrs) |
1.971640E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.273400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.276000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.276600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.500000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.036000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.300600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.241200E-01 |
| Normal-vs-Grade 2 |
1.221880E-02 |
| Normal-vs-Grade 3 |
4.93999999995332E-06 |
| Normal-vs-Grade 4 |
3.93429999999695E-05 |
| Grade 1-vs-Grade 2 |
7.371800E-02 |
| Grade 1-vs-Grade 3 |
9.060700E-03 |
| Grade 1-vs-Grade 4 |
4.703000E-03 |
| Grade 2-vs-Grade 3 |
3.006100E-02 |
| Grade 2-vs-Grade 4 |
2.199500E-02 |
| Grade 3-vs-Grade 4 |
4.597000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.699700E-02 |
| Normal-vs-ccB subtype |
6.611800E-04 |
| ccA subtype-vs-ccB subtype |
3.502300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.836400E-04 |
| Normal-vs-N1 |
4.238000E-01 |
| N0-vs-N1 |
7.077000E-01 |
|
|
